This summer, I’ve spent a lot of time listening to my constituents, and one of the things I hear most often is that prescription drug costs are too high.
We know we can’t rely on prescription drug companies to lower prices. That has been the status quo for too long, and it’s become clear we need a large-scale change if we want to truly address exorbitantly priced prescription drugs.
To read the full article please click here